Abstract

OBJECTIVE:

We explored age-specific and gender-specific effects of fluoride level in drinking water and the incidence of osteosarcoma.

METHODS:

We used data from a matched case-control study conducted through 11 hospitals in the United States that included a complete residential history for each patient and type of drinking water (public, private well, bottled) used at each address. Our analysis was limited to cases less than 20 years old. We standardized fluoride exposure estimates based on CDC-recommended target levels that take climate into account. We categorized exposure into three groups (<30%, 30-99%, >99% of target) and used conditional logistic regression to estimate odds ratios.

RESULTS:

Analysis is based on 103 cases under the age of 20 and 215 matched controls. For males, the unadjusted odds ratios for higher exposures were greater than 1.0 at each exposure age, reaching a peak of 4.07 (95% CI 1.43, 11.56) at age 7 years for the highest exposure. Adjusting for potential confounders produced similar results with an adjusted odds ratio for males of 5.46 (95% CI 1.50, 19.90) at age 7 years. This association was not apparent among females.

CONCLUSIONS:

Our exploratory analysis found an association between fluoride exposure in drinking water during childhood and the incidence of osteosarcoma among males but not consistently among females. Further research is required to confirm or refute this observation.

*Abstract online at https://europepmc.org/article/MED/16596294#funding

Excerpt:

Funders who supported this work: NIDCR NIH, HHS (1)

References 

---

Articles referenced by this article (43)

• Link MP, Eilber F (1997) Osteosarcoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of oediatric oncology, 3rd edn. Lippincott-Raven Co., Philadelphia, pp 889–920

  ---

• Bone cancers.

  Dorfman HD, Czerniak B. Cancer, (1 Suppl):203-210 1995. MED: 8000997

  ---

• Incidence and survival rates of children and young adults with osteogenic sarcoma.

  Homa DM, Sowers MR, Schwartz AG. Cancer, (8):2219-2223 1991. MED: 2004344

  ---

• Miller RW, Boice JD Jr, Curtis RE (1996) Bone cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 971–983

  ---

• Fraumeni JF Jr (1975) Bone cancer: epidemiologic and etiologic considerations. Front Radiat Ther Oncol 10:17–27

  ---

• Miller RW (1981) Contrasting epidemiology of childhood osteosarcoma, Ewing’s tumor, and rhabdomyosarcoma. Natl Cancer Inst Monogr 56:9–14

  ---

• Bone sarcomas linked to radiotherapy and chemotherapy in children.

  Tucker MA, D’Angio GJ, Boice JD Jr, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W. N Engl J Med, (10):588-593 1987. MED: 3475572

  ---

• Radium in drinking water and risk of bone cancer in Ontario youths: a second study and combined analysis.

  Finkelstein MM, Kreiger N. Occup Environ Med, (5):305-311 1996. MED: 8673177

  ---

• Primary bone-forming tumours and their relationship to skeletal growth.

  PRICE CH. J Bone Joint Surg Br, (3):574-593 1958 . MED: 13575473

  ---

• Stature and malignant tumors of bone in childhood and adolescence.

  Fraumeni JF Jr. Cancer, (6):967-973 1967 . MED: 5229526

  ---

• Growth and development and other risk factors for osteosarcoma in children and young adults.

  Gelberg KH, Fitzgerald EF, Hwang S, Dubrow R. Int J Epidemiol, (2):272-278 1997. MED: 9169161

  ---

• Gruber HE, Baylink DJ (1991) The effects of fluoride on bone. Clin Orthop 267:264–277

  ---

• Whitford GM (1996) The metabolism and toxicity of fluoride, 2nd edn. Basil, Karger, pp 1–5, 89–90, 94

  ---

• Results and conclusions of the National Toxicology Program’s rodent carcinogenicity studies with sodium fluoride.

  Bucher JR, Hejtmancik MR, Toft JD 2nd, Persing RL, Eustis SL, Haseman JK. Int J Cancer, (5):733-737 1991 . MED: 2071234

  ---

• Drinking water fluoridation and osteosarcoma.

  Hrudey SE, Soskolne CL, Berkel J, Fincham S. Can J Public Health, (6):415-416 1990 . MED: 2282599

  ---

• Bone cancer incidence rates in New York State: time trends and fluoridated drinking water.

  Mahoney MC, Nasca PC, Burnett WS, Melius JM. Am J Public Health, (4):475-479 1991 . MED: 2003628

  ---

• International trends in the incidence of bone cancer are not related to drinking water fluoridation.

  Freni SC, Gaylor DW. Cancer, (3):611-618 1992. MED: 1623476

  ---

• A case-control study of osteosarcoma in young persons.

  Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR. Am J Epidemiol, (1):118-126 1987 . MED: 3473934

  ---

• Is there a link between fluoridated water and osteosarcoma?

  McGuire SM, Vanable ED, McGuire MH, Buckwalter JA, Douglass CW. J Am Dent Assoc, (4):38-45 1991. MED: 2022786

  ---

• Osteosarcoma, seasonality, and environmental factors in Wisconsin, 1979-1989.

  Moss ME, Kanarek MS, Anderson HA, Hanrahan LP, Remington PL. Arch Environ Health, (3):235-241 1995 . MED: 7618957

  ---

• Fluoride exposure and childhood osteosarcoma: a case-control study.

  Gelberg KH, Fitzgerald EF, Hwang SA, Dubrow R. Am J Public Health, (12):1678-1683 1995. MED: 7503344

  ---

• Hoover RN, Devesa S, Cantor K, Fraumeni JF Jr (1991) Time trends for bone and joint cancers and osteosarcomas in the Surveillance, Epidemiology and End Results (SEER) Program. In: Review of fluoride benefits and risks. U.S. Department of Health and Human Services, Washington, DC (Appendix F)

  ---

• Cohn PD (1992) An epidemiologic report on drinking water and fluoridation. New Jersey Department of Environment Protection and Energy and the New Jersey Department of Health, Trenton

  ---

• McGuire S, Douglass CW, Joshi A, Hunter D, DaSilva J (1995) Fluoride exposure and osteosarcoma. J Dent Res 74(AADR Abstracts):98

  ---

• U.S. Department of Health and Human Services (1988) Fluoridation census, 1985. Department of Health & Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta

  ---

• U.S. Department of Health and Human Services (1993) Fluoridation census, 1992. Department of Health & Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta

  ---

• Problems in exposure assessment of fluoride in drinking water.

  Bassin EB, Mittleman MA, Wypij D, Joshipura K, Douglass CW. J Public Health Dent, (1):45-49 2004 . MED: 15078061

  ---

• Bassin EB (2001) Association between fluoride in drinking water during growth and development and the incidence of osteosarcoma for children and adolescents. Thesis, Harvard School of Dental Medicine, Boston, pp 54–67

  ---

• Reeves TG (1993) Water fluoridation: a manual for water plant operators. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Division of Oral Health, Atlanta, pp 20–21

  ---

• Bogin B (1998) Growth cyclicities and pulsatilities. In: Ulijaszek SJ, Johnston FE, Preece MA (eds) The Cambridge encyclopedia of human growth and development. Cambridge University Press, Cambridge, pp 220–221, 226

  ---

• Analysis of the growth spurt at age seven (mid-growth spurt).

  Molinari L, Largo RH, Prader A. Helv Paediatr Acta, (4):325-334 1980. MED: 7451236

  ---

• Investigation of the mid-growth spurt in height, weight and limb circumferences in single-year velocity data from the London, 1966-67 growth survey.

  Tanner JM, Cameron N. Ann Hum Biol, (6):565-577 1980. MED: 7212642

  ---

• Midgrowth spurt in height of Boston children.

  Berkey CS, Reed RB, Valadian I. Ann Hum Biol, (1):25-30 1983.MED: 6838153

  ---

• Status and strategic plans for fluoridation: Centers for Disease Control and Prevention perspective.

  Reeves TG. J Public Health Dent, (5 Spec No):242-245 1996 . MED: 9034968

  ---

• Effect of nondifferential misclassification on estimates of odds ratios with multiple levels of exposure.

  Birkett NJ. Am J Epidemiol, (3):356-362 1992. MED: 1415154

  ---

• MacMahon B, Trichopoulous D (1996) Epidemiology principles and methods, 2nd edn. Little, Brown and Company, Boston, pp 133–136

  ---

• Induction and latent periods.

  Rothman KJ. Am J Epidemiol, (2):253-259 1981. MED: 7304560

  ---

• Kleerekoper M (1996) Fluoride and the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology. Academic, San Diego, pp 1053–1062

  ---

• WHO (1984) Fluorine and fluorides. World Health Organization, Geneva (Environmental Health Criteria 36)

  ---

• Vaughan J (1981) The Physiology of bone, 3rd edn. Clarendon Press, Oxford, pp 19–20

---

• Soames RW, section ed. (1995) Skeletal system. In: Williams PL (ed) Gray’s anatomy, 38th edn. Churchill Livingstone, New York, pp 425–736

  ---

• Ershow AG, Cantor KP (1989) Total water and tapwater intake in the united states: population-based estimates of quantities and sources. Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, pp 21–24

  ---

• Harris NO, Clark DC (1995) Water fluoridation. In: Harris NO, Christen AG (eds) Primary preventive dentistry, 4th edn. Appleton and Lange, Norwalk, pp 159–161

Print PDF

• Related Studies :

  • A Case-Control Study of Fluoridation and Osteosarcoma.

    Public health policy decisions in the United States have resulted in 62.4% of the population having access to fluoridated water. The purpose of this study was to examine the association between community water fluoridation and osteosarcoma. A secondary data analysis was performed with data collected from 2 separate but linked

  • Bone cancer incidence rates in New York State: time trends and fluoridated drinking water

    BACKGROUND:  Recent animal studies of the potential carcinogenicity of fluoride prompted an examination of bone cancer incidence rates. METHODS:  Trends in the incidence of primary bone cancers, including the incidence of osteosarcomas were examined among residents of New York State, exclusive of New York City. Average annual osteosarcoma incidence rates

  • Results and conclusions of the National Toxicology Program's rodent carcinogenicity studies with sodium fluoride.

    The US National Toxicology Program (NTP) has conducted toxicity and carcinogenicity studies with sodium fluoride administered in the drinking water to F344/N rats and B6C3F1 mice. The drinking water concentrations used in the 2-year studies were 0, 25, 100, or 175 ppm sodium fluoride (equivalent to 0, 11, 45 or

  • Osteosarcoma, seasonality, and environmental factors in Wisconsin, 1979-1989

    Proxy exposure measures and readily available data from the Wisconsin Cancer Reporting System were used to contrast 167 osteosarcoma cases with 989 frequency-matched cancer referents reported during 1979-1989. Differences in potential exposure to water-borne radiation and fluoridated drinking water, population size for the listed place of residence, and seasonality were

  • Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0-49-year-olds in Great Britain, 1980-2005.

    BACKGROUND: Artificial fluoridation of drinking water to improve dental health has long been a topic of controversy. Opponents of this public health measure have cited the possibility of bone cancer induction. The study objective was to examine whether increased risk of primary bone cancer was associated with living in areas

• Related FAN Content :

  • NTP Bioassay on Fluoride/Cancer (1990)

    In 1977, the U.S. Congress requested that animal studies be conducted to determine if fluoride can cause cancer. The result of the Congressional request was an extensive animal study conducted in the 1980s by the National Toxicology Program (NTP) and published in 1990. The main finding of NTP's study was a dose-dependent increase in osteosarcoma (bone cancer) among the fluoride-treated male rats. 

  • Fluoride's Mutagenicity: In vitro Studies

    According to the National Toxicology Program, "the preponderance of evidence" from laboratory "in vitro" studies indicate that fluoride is a mutagenic compound. Many substances which are mutagens, are also carcinogens (i.e. they can cause cancer). As is typical for in vitro studies, the concentrations of fluoride that have generally been tested

  • Fluoride's Mutagenicity: In vivo Studies

    Consistent with dozens of in vitro studies, a number of in vivo studies, in both humans and animals, have found evidence of fluoride-induced genetic damage. In particular, research on humans exposed to high levels of fluoride have found increased levels of "sister chromatid exchange" (SCE). As noted in one study: "In

  • Fluoride & Osteosarcoma: A Timeline

    Several human epidemiological studies have found an association between fluoride in drinking water and the occurrence of osteosarcoma (bone cancer) in young males. These studies are consistent with the National Toxicology Program's (NTP) cancer bioassay which found that fluoride-treated male rats had an dose-dependent increase in osteosarcoma. Although a number of studies have failed to detect an association between fluoride and osteosarcoma, none of these studies have measured the risk of fluoride at specific windows in time, which based on recent results, is the critical question with respect to fluoride and osteosarcoma.

  • Fluoride/Osteosarcoma Link Is Biologically Plausible

    The "biological plausiblility" of a fluoride-osteosarcoma link is widely acknowledged in the scientific literature. The biological plausibility centers around three facts: 1) Bone is the principal site of fluoride accumulation, particularly during the growth spurts of childhood; 2) Fluoride is a mutagen when present at sufficient concentrations, and 3) Fluoride can stimulate the proliferation of osteoblasts (bone-forming cells).